Stock Research: Neuronetics

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Neuronetics

NasdaqGM:STIM US64131A1051
22
  • Value
    6
  • Growth
    93
  • Safety
    Safety
    56
  • Combined
    52
  • Sentiment
    10
  • 360° View
    360° View
    22
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Neuronetics, Inc. is a medical technology and healthcare company that provides non-drug, noninvasive treatments for neurohealth conditions. Its main business is the NeuroStar Advanced Therapy System for major depressive disorder (MDD) and other mental health disorders, and it also offers Spravato for treatment-resistant depression. It operates Greenbrook treatment centers across the United States. In the last fiscal year, the company had a market cap of $246 million, profits of $54 million, revenue of $75 million, and 716 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 22 (better than 22% compared with alternatives), overall professional sentiment and financial characteristics for the stock Neuronetics are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Neuronetics. The consolidated Value Rank has an attractive rank of 56, which means that the share price of Neuronetics is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 56% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 93, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 10. Professional investors are more confident in 90% other stocks. Worryingly, the company has risky financing, with a Safety rank of 6. This means 94% of comparable companies have a safer financing structure than Neuronetics. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
56 25 62 79
Growth
93 65 39 23
Safety
Safety
6 10 82 75
Sentiment
10 33 22 56
360° View
360° View
22 8 59 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
69 37 34 22
Opinions Change
23 50 50 50
Pro Holdings
n/a 65 24 82
Market Pulse
3 17 12 49
Sentiment
10 33 22 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
56 25 62 79
Growth
93 65 39 23
Safety Safety
6 10 82 75
Combined
52 7 70 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
46 46 46 46
Price vs. Earnings (P/E)
85 43 81 89
Price vs. Book (P/B)
34 11 64 92
Dividend Yield
1 1 1 1
Value
56 25 62 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
68 96 35 39
Profit Growth
47 8 56 42
Capital Growth
99 42 59 53
Stock Returns
99 89 25 7
Growth
93 65 39 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
12 18 28 15
Refinancing
65 40 75 95
Liquidity
25 52 62 50
Safety Safety
6 10 82 75

Similar Stocks

Discover high‑ranked alternatives to Neuronetics and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.